#egrx

[alphst]

Eagle Pharmaceuticals (NASDAQ: EGRX): Q4 2019 Earnings Snapshot

Eagle Pharmaceuticals (NASDAQ: EGRX): Q4 2019 Earnings Snapshot

— Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) reported its fourth-quarter 2019 adjusted earnings of $0.48 per share versus $0.46 per share expected.

— Total revenue fell by 14% year-over-year to $48.3 million versus $49.07 million expected. The top line was hurt by lower product sales of Bendeka and Ryanodex and lower argatroban royalty revenue.

— R&D expense jumped by 92% largely due to…

View On WordPress

[ustribunenews-blog]

Dropping The 52 Week Low, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Finishing At $36.74

Dropping The 52 Week Low, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Finishing At $36.74

Eagle Pharmaceuticals Inc (Nasdaq:EGRX)

December 22nd, 2018 Amidst falling markets Eagle Pharmaceuticals Inc finished Friday’s trading session down 3.90%, a $1.49 decrease to close on $36.74. As well as the drop in value, Eagle Pharmaceuticals Inc hit a new 52 week low of $36.55, breaking the previous low of $37.58 from earlier this month. (more…)

View On WordPress

[ustribunenews-blog]

Setting A New 52 Week Low, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Closing Trading At $43.11

Setting A New 52 Week Low, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Closing Trading At $43.11

Eagle Pharmaceuticals Inc (Nasdaq:EGRX)

December 13th, 2018 Eagle Pharmaceuticals Inc fell $1.22 Thursday, down 2.75%, closing at $43.11. As well as the drop in value, Eagle Pharmaceuticals Inc hit a new 52 week low of $43.04, breaking the previous low of $43.34 from earlier this month. In addition to the stock finishing lower, the trading volumes were only 40% of normal which could be an…

View On WordPress

[ustribunenews-blog]

(Nasdaq:EGRX) Eagle Pharmaceuticals Inc Lowers The 52 Week Low

(Nasdaq:EGRX) Eagle Pharmaceuticals Inc Lowers The 52 Week Low

Eagle Pharmaceuticals Inc (Nasdaq:EGRX)

December 10th, 2018 With markets going up Eagle Pharmaceuticals Inc went up $0.54 Monday, up 1.23%, closing at $44.44. Despite ending the day higher, Eagle Pharmaceuticals Inc hit a new 52 week low of $43.34, breaking the previous low of $43.88 from earlier this month. (more…)

View On WordPress

[ustribunenews-blog]

Lowering The 52 Week Low, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Closing At $47.13

Lowering The 52 Week Low, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Closing At $47.13

Eagle Pharmaceuticals Inc (Nasdaq:EGRX)

December 4th, 2018 Amidst falling markets Eagle Pharmaceuticals Inc fell $2.10 Tuesday which equals a 4.27% decline, closing at $47.13. As well as the drop in value, Eagle Pharmaceuticals Inc hit a new 52 week low of $46.38, breaking the previous low of $46.88 from earlier this July. Despite the drop in value, trading volumes were solid at 225% of normal…

View On WordPress

[ustribunenews-blog]

With two Days To Next Earnings Report, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Close At $47.50

With two Days To Next Earnings Report, Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Close At $47.50

Eagle Pharmaceuticals Inc (Nasdaq:EGRX)

October 30th, 2018 Amidst rising markets Eagle Pharmaceuticals Inc finished Tuesday’s trading session down 16.52%, a $9.40 decrease to close on $47.50. With an estimated two days to the next earnings report, everyone is watching Eagle Pharmaceuticals Inc. Sadly, in addition to dropping EGRX ended up closing the day at a new 52 week low.As well as the drop…

View On WordPress

[ustribunenews-blog]

Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Down $13.29

Eagle Pharmaceuticals Inc (Nasdaq:EGRX) Down $13.29

Eagle Pharmaceuticals Inc (Nasdaq:EGRX)

August 30th, 2018

Amidst falling markets Eagle Pharmaceuticals Inc fell $13.29 Thursday, a 16.28% decline, closing at $68.34. Despite the drop in value, trading volumes were solid at 285% of normal which can indicate investor opportunities. (more…)

View On WordPress

[abrcapfinancial-blog]

EARNING UPDATE $EGRX Eagle Pharmaceuticals, Inc. for quarter ending q_Jun18 - Revenue rose but Margins contracted

EARNING UPDATE $EGRX Eagle Pharmaceuticals, Inc. for quarter ending q_Jun18 – Revenue rose but Margins contracted

[s2If !current_user_can(access_s2member_level0)]Please login to read the earning update on EGRX [lwa][/s2If][s2If current_user_can(access_s2member_level0)]Eagle Pharmaceuticals, Inc. reported earnings (EPS) of 0.17 per share for the quarter ending q_Jun18. This is vis-vis 0.17 per share for the previous quarter ending q_Mar18, a decline of 0 %. Compared to last year same quarter (q_Jun17),…

View On WordPress